Drawing for VIFOR PHARMA

USPTO serial 79158397

VIFOR PHARMA

Reviewed by CopyMark Law Group

Reg. 4948439Status 709
Filing date
Status date
Registration date
May 3, 2016
Examiner
JUN, WON KYUNG WENDY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIFOR PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Soaps, perfumery, essential oils, cosmetics, hair lotions; dentifricesSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment and prevention of gastro-intestinal disorders, urinary tract disorders, kidney disorders, capillary hemorrhages, diabetic retinopathy, venous insufficiency; pharmaceutical preparations for the treatment of gastrointestinal discomforts and gastrointestinal diseases, iron deficiency, iron deficiency anemia, disorders of the central nervous system, ophthalmic diseases, disorders of the respiratory system, heart conditions and other disorders of the cardiovascular system, diabetes and related diseases, and migraines and other forms of headache; Pharmaceutical products for the treatment of acute or chronic conditions or consequences of or associated with acute or chronic renal disease, such as acute renal insufficiency, intrinsic kidney disease, glomerulonephritis, tubular disorders and tubulointerstitial diseases, vasculitis of the kidney, vascular injury to the kidney, infection related kidney disorders, kidney neoplasms, congenital and genetic disorders, cystic disorders of the kidney, systemic diseases effecting the kidney, and toxin damage to the kidney; analgesics; antiviral; anti-infectives; anti-inflammatories; antibiotics; antidepressants; anti-cancer preparations; pharmaceutical preparations for use in organ and tissue transplantation; preparations for the treatment of immunologic diseases; pharmaceutical preparations for dialysis and conditions associated with dialysis; preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for treatment of water and electrolyte metabolism disorders and disorders associated with dialysis; medicated lotions for the skin and hair; decongestants and anti-histamines; preparations used as immune system stimulators; scabicides; anti-malarials; cough treatment preparations, namely, cough suppressants; preparations for treating coughs and colds; expectorants; anti-leukemic agents; dermatologicals; tissue sealants; vasopressors; pharmaceutical preparations, namely, nondepolarizing skeletal neuromuscular blocking agents; preparations for the treatment of gout; preparations for cessation of smoking; preparations of treatment of Parkinson's disease; vaccines; antiemetics; nasal spray preparations; sanitary preparations for medical uses; parapharmaceutical products for use in dermatology; dietetic foods, namely, dietary supplement; preparations containing unsaturated fatty acids, vitamins and minerals, nutraceuticals for use as a dietary supplement adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teeth; dental wax; all-purpose disinfectantsSECTION 71 - CANCELLED—
035Import agency services in the field of medicines and pharmaceutical preparations; retail store services featuring pharmaceutical and sanitary preparations; import-export agencies in the fields of medicines, pharmaceutical and sanitary preparationsSECTION 71 - CANCELLED—
039Transport, storage, delivery, and packaging of goods, namely, medicines, pharmaceutical and sanitary preparationsSECTION 71 - CANCELLED—
041Business training services as relating to pharmaceutical and sanitary productsSECTION 71 - CANCELLED—
042Research and development of medicines, pharmaceutical preparations and sanitary care products for othersSECTION 71 - CANCELLED—
045Legal services and legal representation of third parties to the authorities and administration with respect to approval of medicinesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2025Further Decision Processed by IB—
Mar 21, 2025XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 21, 2025INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 21, 2025XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 18, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 18, 2022C71TCANCELLED SECTION 71—
Nov 30, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 13, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Oct 5, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 9, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 9, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 3, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 3, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 12, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 27, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 27, 2016NPUBNOTICE OF PUBLICATION—
Jan 13, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 11, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 7, 2016CNEAEXAMINERS AMENDMENT MAILED—
Jan 7, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 6, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 5, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 5, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 9, 2015CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 8, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 9, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2015ALIEASSIGNED TO LIE—
May 27, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 6, 2015RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2015RFRRREFUSAL PROCESSED BY MPU—
Jan 13, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 11, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 10, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2015DOCKASSIGNED TO EXAMINER—
Jan 8, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2015SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance